Advancing understanding and treatment for genetic lung and liver disease
Using patient-derived stem cells to model and understand disease mechanisms in COPD and alpha-1 antitrypsin deficiency
Our Mission
The Wilson Lab focuses on chronic obstructive pulmonary disease (COPD) and its most common monogenic cause, alpha-1 antitrypsin deficiency (AATD). We use patient-derived stem cells to model and understand disease mechanisms, working toward better treatments for genetic causes of lung and liver disease.
Explore Our ResearchOpen-Source Biology
Part of the CReM initiative providing freely downloadable protocols and access to iPSC lines through our repository.
Learn More →Interactive Datasets
Explore our single-cell RNA sequencing data through interactive web applications and downloadable analysis files.
Access Datasets →Alpha-1 Center
Clinical care and research for alpha-1 antitrypsin deficiency at Boston University Medical Center.
Visit Alpha-1 Center →Join Our Team
The Wilson Lab has openings for laboratory technicians and postdoctoral fellows. Highly qualified applicants are encouraged to contact Dr. Wilson for more information.
Get in Touch